Jane Antony

3.8k total citations
16 papers, 448 citations indexed

About

Jane Antony is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Jane Antony has authored 16 papers receiving a total of 448 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 9 papers in Molecular Biology and 5 papers in Immunology. Recurrent topics in Jane Antony's work include Cancer Cells and Metastasis (6 papers), Pancreatic and Hepatic Oncology Research (5 papers) and Phagocytosis and Immune Regulation (5 papers). Jane Antony is often cited by papers focused on Cancer Cells and Metastasis (6 papers), Pancreatic and Hepatic Oncology Research (5 papers) and Phagocytosis and Immune Regulation (5 papers). Jane Antony collaborates with scholars based in United States, Singapore and United Kingdom. Jane Antony's co-authors include Ruby Yun‐Ju Huang, Jean Paul Thiery, Hani Gabra, Chiara Recchi, Tuan Zea Tan, Jeffrey Low, Mahesh Choolani, Evdoxia Karali, Maddalena Adorno and James R. Birtley and has published in prestigious journals such as Nature Communications, Cancer Research and Scientific Reports.

In The Last Decade

Jane Antony

16 papers receiving 446 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jane Antony United States	10	207	185	165	79	46	16	448
Sonia Brockway United States	7	300 1.4×	171 0.9×	167 1.0×	91 1.2×	17 0.4×	8	472
Shane Foo United Kingdom	7	228 1.1×	195 1.1×	241 1.5×	64 0.8×	49 1.1×	12	508
Katie E. Hebron United States	8	164 0.8×	97 0.5×	118 0.7×	48 0.6×	26 0.6×	12	348
Haley L. Peters United States	10	174 0.8×	175 0.9×	112 0.7×	81 1.0×	49 1.1×	11	381
Haritha Mathsyaraja United States	10	373 1.8×	131 0.7×	81 0.5×	138 1.7×	38 0.8×	10	520
Kun Cai China	6	274 1.3×	100 0.5×	64 0.4×	82 1.0×	41 0.9×	9	397
Valeria Cambiaghi Italy	9	335 1.6×	168 0.9×	126 0.8×	85 1.1×	14 0.3×	10	520
Valentina Montagnani Italy	10	442 2.1×	221 1.2×	84 0.5×	74 0.9×	26 0.6×	10	564
Angela M. Gocher United States	5	264 1.3×	326 1.8×	320 1.9×	94 1.2×	91 2.0×	7	662
Marsha Pellegrino Italy	13	212 1.0×	169 0.9×	103 0.6×	40 0.5×	14 0.3×	19	409

Countries citing papers authored by Jane Antony

Since Specialization

Citations

This map shows the geographic impact of Jane Antony's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane Antony with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane Antony more than expected).

Fields of papers citing papers by Jane Antony

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jane Antony. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane Antony. The network helps show where Jane Antony may publish in the future.

Co-authorship network of co-authors of Jane Antony

This figure shows the co-authorship network connecting the top 25 collaborators of Jane Antony. A scholar is included among the top collaborators of Jane Antony based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jane Antony. Jane Antony is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Smith, Allan Ben, Hayley Russell, Lisa Beatty, et al.. (2025). Assessing the impact of a self-guided digital intervention for fear of cancer recurrence (iConquerFear) in ovarian cancer survivors: a pilot randomised waitlist-controlled trial. BMC Cancer. 25(1). 527–527. 1 indexed citations

Sikandar, Shaheen S., Gunsagar S. Gulati, Jane Antony, et al.. (2022). Identification of a minority population of LMO2 ⁺ breast cancer cells that integrate into the vasculature and initiate metastasis. Science Advances. 8(45). eabm3548–eabm3548. 3 indexed citations

Reinitz, Felicia, Benedetta Nicolis di Robilant, Bayarsaikhan Chuluun, et al.. (2022). Inhibiting USP16 rescues stem cell aging and memory in an Alzheimer’s model. eLife. 11. 9 indexed citations

Weele, Linda J. van, Sabra Djomehri, Shang Cai, et al.. (2022). Mesenchymal tumor cells drive adaptive resistance of Trp53^−/− breast tumor cells to inactivated mutant Kras. Molecular Oncology. 16(17). 3128–3145. 1 indexed citations

Reinitz, Felicia, Benedetta Nicolis di Robilant, Bayarsaikhan Chuluun, et al.. (2022). Inhibiting USP16 rescues stem cell aging and memory in an Alzheimer's model.. PubMed. 11. 6 indexed citations

Antony, Jane, et al.. (2021). Applications of the Chick Chorioallantoic Membrane as an Alternative Model for Cancer Studies. Cells Tissues Organs. 211(2). 222–237. 65 indexed citations

Zabala, Maider, Neethan A. Lobo, Jane Antony, et al.. (2020). LEFTY1 Is a Dual-SMAD Inhibitor that Promotes Mammary Progenitor Growth and Tumorigenesis. Cell stem cell. 27(2). 284–299.e8. 12 indexed citations

Antony, Jane, et al.. (2020). Emerging roles for the GPI-anchored tumor suppressor OPCML in cancers. Cancer Gene Therapy. 28(1-2). 18–26. 10 indexed citations

Birtley, James R., Mohammad N. Alomary, Jane Antony, et al.. (2019). Inactivating mutations and X-ray crystal structure of the tumor suppressor OPCML reveal cancer-associated functions. Nature Communications. 10(1). 3134–3134. 9 indexed citations

10.

Antony, Jane, Jean Paul Thiery, & Ruby Yun‐Ju Huang. (2019). Epithelial-to-mesenchymal transition: lessons from development, insights into cancer and the potential of EMT-subtype based therapeutic intervention. Physical Biology. 16(4). 41004–41004. 48 indexed citations

11.

Antony, Jane, Tuan Zea Tan, Evdoxia Karali, et al.. (2018). The tumour suppressor OPCML promotes AXL inactivation by the phosphatase PTPRG in ovarian cancer. EMBO Reports. 19(8). 26 indexed citations

12.

Adorno, Maddalena, Benedetta Nicolis di Robilant, Shaheen S. Sikandar, et al.. (2018). Usp16 modulates Wnt signaling in primary tissues through Cdkn2a regulation. Scientific Reports. 8(1). 17506–17506. 8 indexed citations

13.

Antony, Jane, Evdoxia Karali, Imoh S. Okon, et al.. (2017). The Tumor-Suppressor Protein OPCML Potentiates Anti–EGFR- and Anti–HER2-Targeted Therapy in HER2-Positive Ovarian and Breast Cancer. Molecular Cancer Therapeutics. 16(10). 2246–2256. 21 indexed citations

14.

Antony, Jane & Ruby Yun‐Ju Huang. (2017). AXL-Driven EMT State as a Targetable Conduit in Cancer. Cancer Research. 77(14). 3725–3732. 124 indexed citations

15.

Antony, Jane, Tuan Zea Tan, Jeffrey Low, et al.. (2016). The GAS6-AXL signaling network is a mesenchymal (Mes) molecular subtype–specific therapeutic target for ovarian cancer. Science Signaling. 9(448). ra97–ra97. 94 indexed citations

16.

Huang, Ruby Yun‐Ju, Jane Antony, Tuan Zea Tan, & David S.P. Tan. (2016). Targeting the AXL signaling pathway in ovarian cancer. Molecular & Cellular Oncology. 4(2). e1263716–e1263716. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact